A Phase I, Open-label, Randomized, 2-panel, Sequential Treatment Study in Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Multiple Doses of Phenytoin or Carbamazepine and Telaprevir at Steady-state
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Carbamazepine (Primary) ; Phenytoin (Primary) ; Telaprevir (Primary)
- Indications Bipolar disorders; Epilepsy; Hepatitis C
- Focus Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 30 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Jul 2012 New trial record